Effect of Calbindni-D28K on cyclosporine toxicity in cultured renal proximal tubular cells

Journal of Cellular Physiology

Volumn 200, Issue 3, 2004, Pages 395-399

  Wu, Ming Ju ^a,b   Lai, Li Wen ^c   Lien, Yeong Hau H ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; CALCIUM; CALCIUM BINDING PROTEIN; CALPAIN; CASPASE; COMPLEMENTARY DNA; CYCLOSPORIN; FURA 2; LACTATE DEHYDROGENASE; LIPOSOME; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DNA TRANSFECTION; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME RELEASE; GENE TRANSFER; KIDNEY PROXIMAL TUBULE; MOUSE; NEPHROTOXICITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; TIME; TOXICITY TESTING;

CUCUMBER MOSAIC VIRUS; MURINAE;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALPAIN; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CYCLOSPORINE; CYTOPROTECTION; FURA-2; KIDNEY TUBULES, PROXIMAL; L-LACTATE DEHYDROGENASE; MICE; RNA, MESSENGER; TIME FACTORS; TOXICITY TESTS;

EID: 3442882154     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20028     Document Type: Article

References (31)

1. Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, Steiner S. 1997. Decrease in kidney calbindin-D 28 kDa as a possible mechanism mediating cyclosporine A- and FK-506- induced calciuria and tubular mineralization. Biochem Pharmacol 53:723-731.
2. Bennet WM, Pulliam JP. 1983. Cyclosporine nephrotoxicity. Ann Intern Med 305:267-273.
3. Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS. 1986. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation 41:177-181.
4. Cheng CH, Hsiech CL, Shu KH, Chen LY, Chen HC. 2002. Effect of calcium channel antagonist diltiazem and calcium ionophore A23187 on cyclosporine A-induced apoptosis of renal tubular cells. FEBS Lett 516:191-196.
5. Cheung JY, Bonventre JV, Malis CD, Leaf A. 1986. Calcium and ischemic injury. N Engl J Med 314:1670-1676.
6. Christakos S, Gabrielides C, Rhoten WB. 1989. Vitamin D-dependant calcium binding proteins: Chemistry, distribution, functional considerations, and molecular biology. Endocr Rev 10:3-26.
7. Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfeld RL. 1992. Stable expression of the calbidin-D28k complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 6:1843-1848.
8. Edelstein CL, Ling H, Schrier RW. 1997. The nature of renal cell injury. Kidney Int 51:1341-1351.
9. Gossmann J, Mondorf U, Dietz A, Kramer W, Kachel H-G, Geiger H, Scheuermann EH. 2002. A randomized prospective double-blind placebo-controlled study of Gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients. Transplant Proc 34:1767-1770.
10. Gross M, Kumar R. 1990. Physiology and biochemistry of vitamin D-dependant calcium binding proteins. Am J Physiol 259:F195-F209.
11. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe M, Harper RA, Kefalides NA, Neilson EG. 1988. Characterization of a renal tubular epithelial cell line which secretes the autologous target of autoimmune experimental interstital nephritis. J Cell Biol 107:1359-1368.
12. 2+ overload in primary cultures of rat renal cortical epithelial cells by cytotoxic concentrations of cyclosporine: A digitized fluorescence imaging study. Toxicology 95:155-166.
13. Kahan BD. 1986. Cyclosporine nephrotoxiicty: Pathogenesis, prophylaxis, therapy and prognosis. Am J Kidney Dis 8:323-331.
14. Lee CT, Huynh VM, Lai L, Lien YH. 2002. Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild type mice. Kidney Int 62:2055-2061.
15. 28k via herpes simplex virus amplicon vector decrease calcium ion mobilization and enhances neuronal survival after hypoglycemia challenge. J Neurochem 69:1039-1047.
16. Meyer-Lehnert H, Schrier RW. 1989. Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction. Hypertension 13:352-360.
17. Meyer-Lehnert H, Bokermeyer D, Friedrichs U, Backer A, Kramer HJ. 1997. Cellular mechanisms of cyclosporine A-associated side-effects: role of endothelin. Kidney Int 52(Suppl 61):S27-S31.
18. Mihatsch MJ, Thiel G, Basler V, Ryffel B, Landmann J, von Overbeck J, Zollinger HU. 1985. Morphological patterns in cyclosporine-treated renal transplant recipients. Transplant Proc 4(Suppl 1):101-116.
19. Mihatsch MJ, Ryffel B, Hermle M, Brunner FP, Thiel G. 1986. Morphology of cyclosporine nephrotoxicity in the rat. Clin Nephrol 25(Suppl 1):S2-S8.
20. -- dependent betaine transporter in rat renal medulla. Am J Physiol 272:F100-F106.
21. Nakahama H, Fukunaga M, Kakihara M, Horio M, Fujiwara Y, Fukuhara Y, Ueda N, Orita Y, Kamada T. 1991. Comparative effects of cyclosporine A and FK506 on endothelin secretion by a cultured renal cell line, LLC-PK1. J Cardiovasc Pharmacol 17(Suppl 7):S172-S173.
22. Ortiz A, Lorz C, Catalan M, Ortiz A, Coca S, Egido J. 1998. Cyclosporine A induces apoptosis in murine tubular epithelial cells: Role of caspases. Kidney Int 54(S68):S25-S29.
23. Pfeilschifter J. 1988. Cyclosporin A augments vasoconstrictor-induced rise in intracellular free calcium in rat renal mesangial cells. Biochem Pharmacol 37:4205-4210.
24. Pfeilschifter J, Ruegg UT. 1987. Cyclosporine A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J 248:883-887.
25. Rump LC, Oberhauser V, Schwertgeger E, Speidel L, Zimmerhackl L, Kirste G, Grotz W. 2002. Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients. J Hypertens 18:1115-1119.
26. Russo AL, Passaquin AC, Andre P, Skutella M, Ruegg UT. 1996. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: Possible lack of relationship to immunosuppressive activity. Br J Pharmacol 118:885-892.
27. Thadhani R, Pascual M, Bonventre JV. 1996. Acute renal failure. N Engl J Med 334:1448-1460.
28. 0 and progression into S phase. Mol Biol Cell 4:293-302.
29. Wilson PD, Hartz PA. 1991. Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: A role for cysteine proteases. Cell Biol Int Reports 15:1243-1258.
30. Wu MJ, Lai LW, Lien YH. 2002. Cytoprotective effects of calbindin-D28k against antimycin-A induced hypoxic injury in proximal tubular cells. Life Sci 71:559-569.
31. Zimmerhackl LB, Mesa H, Hramer F, Kolmel C, Wiegele G, Brandis M. 1997. Tubular toxicity of cyclosporine A and the influence of endothelin-1 in renal culture models (LLC-PK1 and MDCK). Pediatr Nephrol 11:778-783.